Home › Stocks › LLY vs ABBV
LLY
Eli Lilly and Company
$1,008.04
vs
ABBV
AbbVie Inc.
$209.41

Head-to-Head Comparison

MetricLLYABBV
Market Cap$750.0B$370.0B
P/E Ratio65.018.0
Div YieldN/AN/A
SectorHealthcareHealthcare
Beta0.480.30
RevenueN/AN/A
Net IncomeN/AN/A
EPSN/AN/A

AI Comparison Brief

AI Generated
Verdict
AbbVie Inc. (ABBV) is the superior investment compared to Eli Lilly and Company (LLY) at this time. While both companies operate within the same sector, ABBV's established market cap of $369.98 billion and lower beta of 0.305 indicate a more stable investment profile. Additionally, AbbVie's strong product portfolio and revenue generation position it favorably for future growth, whereas LLY lacks sufficient data to assess its valuation or growth potential effectively.
Key Differences
  • Market Capitalization: ABBV boasts a significant market cap of $369.98 billion, indicating a well-established presence in the healthcare sector, whereas LLY's market cap is not available, raising concerns about its stability.
  • Risk Profile: ABBV's lower beta of 0.305 suggests less volatility compared to LLY's beta of 0.481, making ABBV a more conservative investment choice during market fluctuations.
  • Growth Trajectory: Although both companies are in drug manufacturing, ABBV has a proven track record of successful drug launches and revenue growth, while LLY's lack of available earnings data makes its growth trajectory unclear.
  • Dividend Consideration: Neither company currently offers a dividend yield, but ABBV's established market presence and revenue generation capabilities may lead to future dividend payouts, which are absent for LLY.
Bottom Line
Investors seeking a more stable and potentially rewarding option should opt for AbbVie Inc. (ABBV), while those willing to accept higher uncertainty for potential growth may consider Eli Lilly and Company (LLY) if more data becomes available.
This comparison is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Analysis generated 2026-06-02

Price Chart — LLY vs ABBV

Loading chart...
→ Eli Lilly and Company (LLY) Full Analysis → AbbVie Inc. (ABBV) Full Analysis ← Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms